SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPinewood Technologies Group Regulatory News (PINE)

Share Price Information for Pinewood Technologies Group (PINE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    3.50 (1.45%)
Bid:
244.50
Ask:
246.50
Spread: 2.00 (0.818%)
Market Cap: £281.99m
PINE Live PriceLast checked at - London Stock Exchange

Intraday Pinewood Technologies Group Share Chart

Form 8.5 (EPT/NON-RI) Pinewood Technologies Group

4 Feb 2026 10:41

RNS Number : 7184R
Jefferies International Limited
04 February 2026
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Jefferies International Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Pinewood Technologies Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Pinewood Technologies Group Plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

3rd February 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

100p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

836

0.001

 

 

(2) Cash-settled derivatives:

 

 

 

1,452

0.001

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

836

0.001

1,452

0.001

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

 

 

 

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

100p ordinary

Purchase

 

Sale

21,360

 

21,360

476.2500 GBX

 

476.2500 GBX

474.0000 GBX

 

475.6093 GBX

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBX)

100p ordinary

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

-

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

4th February 2026

Contact name:

Jason Williams

Telephone number:

020 7029 8706

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOFZGGZGDNGVZM
Date   Source Headline
25th Sep 202512:13 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSHalf year results for the 6 months to 30 June 2025
15th Sep 20257:00 amRNSInclusion in FTSE 250 Index
11th Sep 20256:00 pmRNSWarehouse REIT
26th Aug 20255:26 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSHolding(s) in Company
4th Aug 202512:00 pmRNSCompletion of PWSA Business Acquisition
4th Aug 202511:41 amRNSHolding(s) in Company
4th Aug 20257:00 amRNSNotice of Interim Results
1st Aug 20259:00 amRNSHolding(s) in Company
31st Jul 20258:03 amRNSCompletion of Lithia JV Acquisition & Admission
30th Jul 20252:00 pmRNSAdmission of New Ordinary Shares
28th Jul 20257:00 amRNSAmendment of Acquisition Agreement
25th Jul 20253:35 pmRNSDirector/PDMR Shareholding
7th Jul 202511:28 amRNSDirector/PDMR Shareholding
7th Jul 20257:00 amRNSAcquisition of Pinewood South Africa Business
1st Jul 20253:23 pmRNSHolding(s) in Company
30th Jun 20254:10 pmRNSResults of AGM & General Meeting
27th Jun 20254:13 pmRNSDirector/PDMR Shareholding
12th Jun 20252:40 pmRNSDirector/PDMR Shareholding
6th Jun 20253:38 pmRNSPublication of Prospectus
6th Jun 20257:00 amRNSAcquisition of Lithia’s Stake in North America JV
4th Jun 202512:00 pmRNSBoard composition update
28th May 20257:00 amRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSignificant New Contract Award
28th Apr 20252:51 pmRNSDirector/PDMR Shareholding
17th Apr 202511:29 amRNSPublication of the Annual Report & Accounts FY24
1st Apr 20257:00 amRNSFinal Results
28th Mar 20259:00 amRNSDirector/PDMR Shareholding
28th Mar 20259:00 amRNSDirector Declaration
20th Mar 20254:24 pmRNSNotice of Results
3rd Mar 20252:00 pmRNSIssue of Seez Consideration Shares
27th Feb 20257:00 amRNSDirector/PDMR Shareholding
25th Feb 20251:54 pmRNSDirector/PDMR Shareholding
25th Feb 202512:00 pmRNS-RCommencement of Trading on OTCQX in the U.S.
21st Feb 20257:00 amRNSResult of Equity Fundraise
20th Feb 20254:40 pmRNSRetailBook Offer
20th Feb 20254:36 pmRNSEquity Fundraise
20th Feb 20254:35 pmRNSProposed Acquisition of Seez
14th Feb 20257:00 amRNSSignificant New Contract Award and Trading Update
12th Feb 202511:10 amRNSHolding(s) in Company
28th Jan 202512:09 pmRNSDirector/PDMR Shareholding
30th Dec 20247:00 amRNSPDMR Transaction Notification
20th Dec 20244:46 pmRNSHolding(s) in Company
26th Nov 202412:02 pmRNSDirector/PDMR Shareholding
22nd Nov 202411:45 amRNSDirector/PDMR Shareholding
15th Nov 202412:34 pmRNSHolding(s) in Company
5th Nov 20241:02 pmRNSDirector/PDMR Shareholding
1st Nov 20248:09 amRNSDirector/PDMR Shareholding
25th Oct 202411:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.